Esperion Therapeutics, Inc. (ESPR)
3.275
-0.08
(-2.24%)
USD |
NASDAQ |
Mar 02, 16:00
3.27
0.00 (0.00%)
After-Hours: 19:38
Esperion Therapeutics Research and Development Expense (Annual) : 46.24M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Nektar Therapeutics | 119.64M |
| Rigel Pharmaceuticals, Inc. | 23.38M |
| Harrow, Inc. | 12.95M |
| AnaptysBio, Inc. | 163.23M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |